Justas2010 (Talk | contribs) |
Justas2010 (Talk | contribs) |
||
Line 26: | Line 26: | ||
<h1>Description</h1> | <h1>Description</h1> | ||
<p></p> | <p></p> | ||
− | + | At the beginning of the InterLab study we completed three distinct calibration protocols. At first, we performed the <strong>LUDOX Protocol</strong> in order to obtain a conversion factor to transform absorbance (Abs<sub>600</sub>) from the plate reader into a comparable OD<sub>600</sub> measurement as would be obtained with a spectrophotometer. Next, we completed the <strong>Microsphere Protocol</strong> as it allows a standard curve of particle concentration which is used to convert Abs<sub>600</sub> measurements to an estimated number of cells. Finally, by completing the <strong>Fluorescein Protocol</strong> we generated a standard fluorescence curve which is used to compare fluorescence output of different test devices. Completion of the calibrations ensured that we take cell measurements under the same conditions. It is worth mentioning that prior calibration, we prepared competent E. coli DH5-alpha cells and transformed them according to the standard transformation protocol. During all of the experiments we tested 8 plasmids: 2 controls and 6 test devices (Tab 1). | |
− | + | <p></p><strong>Tab. 1</strong> Parts received and tested during iGEM’s fifth InterLab Study | |
<table> | <table> | ||
<thead> | <thead> | ||
Line 39: | Line 39: | ||
<tr> | <tr> | ||
<td>Negative control</td> | <td>Negative control</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_R0040"> | + | <td><a href="http://parts.igem.org/Part:BBa_R0040"> BBa_R0040 </td> |
<td>Medium strength promoter, promoter is constitutive and repressed by TetR | <td>Medium strength promoter, promoter is constitutive and repressed by TetR | ||
</td> | </td> | ||
Line 45: | Line 45: | ||
<tr> | <tr> | ||
<td>Positive Control</td> | <td>Positive Control</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_I20270">BBa_I20270</td> | + | <td><a href="http://parts.igem.org/Part:BBa_I20270"> BBa_I20270 </td> |
<td>J23151 inserted in the Promoter MeasKit</td> | <td>J23151 inserted in the Promoter MeasKit</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 1</td> | <td>Test Device 1</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364000"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364000"> BBa_J364000 </td> |
<td>GFP expressing constitutive device</td> | <td>GFP expressing constitutive device</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 2</td> | <td>Test Device 2</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364001"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364001"> BBa_J364001 </td> |
<td>GFP expressing constitutive device</td> | <td>GFP expressing constitutive device</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 3</td> | <td>Test Device 3</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364002"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364002"> BBa_J364002 </td> |
<td>GFP expressing constitutive device</td> | <td>GFP expressing constitutive device</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 4</td> | <td>Test Device 4</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364007"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364007"> BBa_J364007 </td> |
<td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 5</td> | <td>Test Device 5</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364008"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364008"> BBa_J364008 </td> |
<td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 6</td> | <td>Test Device 6</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364009"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364009"> BBa_J364009 </td> |
<td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | ||
</tr> | </tr> | ||
Line 104: | Line 104: | ||
<tr> | <tr> | ||
<td>Negative control</td> | <td>Negative control</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_R0040"> | + | <td><a href="http://parts.igem.org/Part:BBa_R0040"> BBa_R0040 </td> |
− | <td>Medium strength promoter, promoter is constitutive and repressed by TetR</td> | + | <td>Medium strength promoter, promoter is constitutive and repressed by TetR |
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Positive Control</td> | <td>Positive Control</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_I20270"> | + | <td><a href="http://parts.igem.org/Part:BBa_I20270"> BBa_I20270 </td> |
<td>J23151 inserted in the Promoter MeasKit</td> | <td>J23151 inserted in the Promoter MeasKit</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 1</td> | <td>Test Device 1</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364000"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364000"> BBa_J364000 </td> |
<td>GFP expressing constitutive device</td> | <td>GFP expressing constitutive device</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 2</td> | <td>Test Device 2</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364001"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364001"> BBa_J364001 </td> |
<td>GFP expressing constitutive device</td> | <td>GFP expressing constitutive device</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 3</td> | <td>Test Device 3</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364002"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364002"> BBa_J364002 </td> |
<td>GFP expressing constitutive device</td> | <td>GFP expressing constitutive device</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 4</td> | <td>Test Device 4</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364007"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364007"> BBa_J364007 </td> |
<td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 5</td> | <td>Test Device 5</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364008"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364008"> BBa_J364008 </td> |
<td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
<td>Test Device 6</td> | <td>Test Device 6</td> | ||
− | <td><a href="http://parts.igem.org/Part:BBa_J364009"> | + | <td><a href="http://parts.igem.org/Part:BBa_J364009"> BBa_J364009 </td> |
<td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | <td>Expresses GFP under the control of a constitutive promoter from the Anderson collection</td> | ||
</tr> | </tr> | ||
Line 152: | Line 153: | ||
<p>Monodisperse silica microspheres exhibit size and optical characteristics similar to cells, with the additional benefit that the number of particles in a solution is known. Therefore, this measurement allowed us to construct a standard curve which can be used to convert Abs<sub>600</sub> measurements to an estimated number of cells. | <p>Monodisperse silica microspheres exhibit size and optical characteristics similar to cells, with the additional benefit that the number of particles in a solution is known. Therefore, this measurement allowed us to construct a standard curve which can be used to convert Abs<sub>600</sub> measurements to an estimated number of cells. | ||
</p> | </p> | ||
− | <img src="https://static.igem.org/mediawiki/2018/3/31/T--Vilnius-Lithuania--1_InterLab.png" | + | <<img src="https://static.igem.org/mediawiki/2018/3/31/T--Vilnius-Lithuania--1_InterLab.png"> |
<p><strong>Fig. 1</strong> LUDOX CL-X measurement. Obtained ratiometric conversion factor is 3,419.</p> | <p><strong>Fig. 1</strong> LUDOX CL-X measurement. Obtained ratiometric conversion factor is 3,419.</p> | ||
<p></p> | <p></p> | ||
Line 167: | Line 168: | ||
<p>In the last part of the calibration we prepared a dilution series of fluorescein in four replicates and measured the fluorescence. During this calibration part we generated a standard curve of fluorescence for fluorescein concentration.</p> | <p>In the last part of the calibration we prepared a dilution series of fluorescein in four replicates and measured the fluorescence. During this calibration part we generated a standard curve of fluorescence for fluorescein concentration.</p> | ||
<p></p> | <p></p> | ||
− | <img src="https://static.igem.org/mediawiki/2018/b/b0/T--Vilnius-Lithuania--3_InterLab.png" | + | <img src="https://static.igem.org/mediawiki/2018/b/b0/T--Vilnius-Lithuania--3_InterLab.png"> |
<strong>Fig. 3</strong> Standard curve of fluorescein generated by measuring the fluorescence of serial dilution stock (µM). Fluorescence is plotted against the fluorescein concentration.</p> | <strong>Fig. 3</strong> Standard curve of fluorescein generated by measuring the fluorescence of serial dilution stock (µM). Fluorescence is plotted against the fluorescein concentration.</p> | ||
Revision as of 17:21, 17 October 2018
InterLab
Studying Fluorescence
The goal of this year’s InterLab Study was to identify and minimize the sources of systematic variability in fluorescence measurements by normalizing to absolute cell count or colony-forming units (CFUs) instead of optical density (OD).
Participating in the fifth iGEM InterLab Study was a great opportunity to start this year’s competition as well as acquire some valuable knowledge which we implemented into practice during the project.